News & Updates

Get useful insights and updates from us

Latest News

UMediC Group Berhad | CNY Charity

UMediC Group Berhad | CNY Charity

Spreading Joy: A Charity Initiative for Chinese New Year Together, We Bring Light to Those in Need. This year, UMediC carried out meaningful charity initiatives, spreading love on wheels to charity home, ensuring that communities in need also have the opportunity to...

More from news & updates

HLIB sees domestic healthcare sector thriving in 2024

HLIB sees domestic healthcare sector thriving in 2024

  KUALA LUMPUR (Dec 20): The Malaysian healthcare sector is poised for sustained growth in 2024, bolstered by the Ministry of Health's (MOH) enlarged budget allocation and the robust surge in medical tourism, supported by a strategic focus on brownfield expansion...

医疗需求上涨 UMediC首季净赚189万|UMediC`s 1Q net profit at RM1.89mil

医疗需求上涨 UMediC首季净赚189万|UMediC`s 1Q net profit at RM1.89mil

(吉隆坡4日讯)UMediC集团(UMC,0256,创业板)2024财年首季(截至10月杪)净赚189万令吉,比去年同期的200万令吉稍跌5.6%。 集团周一向大马交易所报备,首季营业额则录得1452万令吉,较去年同期高出28.4%。 根据业绩报告,集团首季营业额和税前盈利升增,主要归功于营销、分销及制造业务的带动。其中,公立和私立医院的医疗设备和消耗品需求增加亦是主因之一。 此外,由集团生产的HydroX系列和AirdroX系列的医疗产品也提振了集团收入。...

Better manufacturing capacity to bolster UMediC

Better manufacturing capacity to bolster UMediC

PETALING JAYA: Medical device maker UMediC Group Bhd is anticipated to see improved earnings in the coming quarters owing to its additional manufacturing capacity and a larger allocation for the Health Ministry under Budget 2024. Hong Leong Investment Bank (HLIB)...

UMediC申请转主板上市|UMediC proposes to transfer listing from ACE to Main Market

UMediC申请转主板上市|UMediC proposes to transfer listing from ACE to Main Market

  (吉隆坡27日讯)UMediC集团(UMC,0256,创业板医疗保健组)申请转至主板上市。 该公司向大马股票交易所报备,由于盈利已符合要求,财务状况也稳健,加上公众持股权达32.70%,已超过至少25%的门槛,因此寻求转板上市。 UMediC集团是在2022年7月26日上市,转板活动则预计于2024年上半年完成。     – KLSE Screener  – www.klsescreener.com...

【行家论股】UMediC集团 产能提升带动业绩|Increase in production capacity expected to drive UMediC`s performance

【行家论股】UMediC集团 产能提升带动业绩|Increase in production capacity expected to drive UMediC`s performance

分析:丰隆投行研究 目标价:1.00令吉 最新进展: UMediC集团(UMC,0256,创业板)2024财年首季(截至10月杪)净赚189万令吉,按年跌5.6%。 首季营收录得1452万令吉,按年升28.4%。   行家建议: UMediC集团销售成本提高,导致首季核心净利下滑至180万令吉,仅达到我们和市场全年预期的13%。 然而,我们仍视为符合预测,因为估计该公司产能提升、卫生部预算增加,将带动未来数个季度的业绩增长。 展望未来,该集团的新厂已建设完成,正在申请完工证书,料于年底获得。...

UMediC has prospective earnings growth over the next two years

UMediC has prospective earnings growth over the next two years

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen. In a report, the research house said the fast growing distributor of medical equipment and manufacturer of...